About Me
I am a hematologist who specializes in treating patients with leukemia and other blood cancers. I serve as chairman and professor in the Department of Internal Medicine at The Ohio State University, and also hold the Bertha Bouroncle, MD, and Andrew Pereny Chair in Medicine.
At the OSUCCC – James, we use the latest technologies in our search for more effective and targeted cancer treatments, and then apply our findings to patient care as quickly and responsibly as possible. As a member of the Leukemia and Hematologic Malignancies Program, I have over 30 years of experience in experimental chemotherapy and drug development for patients with chronic lymphocytic leukemia (CLL) and other hematologic malignancies.
I performed the initial phase I studies on purine nucleoside analogs in patients with hematologic malignancies and conducted one of the initial phase II studies of fludarabine in patients with CLL. Together with Dr. John C. Byrd, I was among the first to investigate the potential of histone deacetylase inhibitors (depsipeptide) and cyclin-dependent kinase inhibitors (flavopiridol) in CLL, and I oversaw both laboratory and phase I clinical studies of both these agents.
My work has been published in such well-respected medical journals as Molecular Cancer Therapeutics, Blood and Journal of Clinical Oncology. I have also been honored with a number of awards, including Best Doctors in America, the Distinguished Alumnus Award from University of Pittsburgh, and more recently, The Ohio State University Distinguished Scholar Award. Additionally, I was named to the Castle Connolly list of “America's Top Doctors” from 2006 to 2019.
Highlights
- Named to the Castle Connolly list of “America's Top Doctors”; "America's Top Doctors for Cancer"; “Regional Top Doctors”
- Best Doctor in America, 2017
Procedures and Conditions I Treat
- Hematologic Diseases
- Hematology
- Chronic Lymphocytic Leukemias
- Hairy Cell Leukemia
- Blood Cancers
Education and Training
Education History
Medical School
University of Pittsburgh School of Medicine, Pittsburgh, PA
9/1/1967 - 6/1/1971
Internship
University of Pittsburgh Medical Center, Pittsburgh, PA
7/1/1971 - 6/30/1972
Residency
University of Pittsburgh Medical Center, Pittsburgh, PA
7/1/1972 - 6/30/1974
Fellowship
Ohio State University Wexner Medical Center, Columbus, OH
7/1/1976 - 6/30/1978
Board Certifications
American Board of Internal Medicine
6/18/1975
American Board of Internal Medicine/Medical Oncology
6/19/1979
American Board of Internal Medicine/Hematology
11/1/1988
Academic Information
My Department
Internal Medicine
My Division
Hematology
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 09/30/2022, Dr. Grever has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.
- Hairy Cell Leukemia Foundation
- Dicephera Pharmaceutical
